The study of bronchospastic eicosanoids levels in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017
Aspirin-induced asthma as the pathology of the platelet‘s melatonin production Source: Eur Respir J 2006; 28: Suppl. 50, 236s Year: 2006
Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
The pathology of the platelet‘s melatonin production in aspirin-induced asthma Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma Source: Eur Respir J 2002; 19: 872-878 Year: 2002
Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Roflumilast inhibits chemokine release in animal models of COPD and asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004
Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006
Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Levofloxacin prevents eosinophil activation and asthma exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001
The activity of anti-oxidative enzymes in subjects with asthma and bronchial hyperreactivity Source: Annual Congress 2005 - Novelties in asthma progression and risks Year: 2005
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012
Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012